Nicholas Kadysh profile page

With over a decade of experience as a Public Affairs and Regulatory expert, Nick Kadysh is the founder and CEO of PharmAla Biotech, the first publicly-traded company to manufacture GMP MDMA, and a leading researcher of pre-clinical MDMA Analogs. Nick is also the inaugural Chair of the Board at PsyCan, the trade association for the legal, for-profit psychedelics sector in Canada. Prior to launching PharmAla in 2020, Nick led government relations and regulatory departments for several large corporations, including as Head of Corporate Affairs for JUUL Labs, as Government Affairs & Public Policy Leader for General Electric Canada, and as Director of Public Affairs for Red Bull Canada. Nick gained a deep understanding of government as a campaign and legislative staff member in multiple levels of government prior to joining the corporate sector, serving as a senior staffer in the Parliaments of Canada and Ontario.